Frequently Asked Questions
The market is segmented based on North America Anti-Snoring Devices and Snoring Surgery Market, By Product Type (Oral Appliances/Mouthpieces, Nasal Devices, Position Control Devices, Chin Straps, EPAP Therapy Devices and Continuous Positive Airway Pressure (CPAP) Devices), Device Type (Mandibular Advancement Devices (MAD), Tongue Stabilizing Device (TSD), Continuous Positive Airway Pressure (CPAP) Devices, Others), Surgery Type (Uvulopalatopharyngoplasty UPPP, Tonsillectomy and Adenoidectomy Surgery, Maxillo-mandibular and Genioglossus Advancement Surgeries, Laser-Assisted Uvulopalatoplasty LAUP, Radiofrequency Ablation, Pillar Procedure, Palatal Stiffening Procedures, Injection Snoreplasty and Others), Mode of Purchase (Over the Counter and Prescription Based), Gender (Male and Female), End User (Hospitals, Community Healthcare, Sleep Clinics, Home Healthcare and Others), Distribution Channel (Direct Tenders, Retail Sales and Online Sales) – Industry Trends and Forecast to 2030.
.
The North America Anti Snoring Devices And Snoring Surgery Market size was valued at USD 1.53 USD Billion in 2022.
The North America Anti Snoring Devices And Snoring Surgery Market is projected to grow at a CAGR of 7.7% during the forecast period of 2023 to 2030.
The major players operating in the market include Apnea Sciences, The Pure Sleep Company, KELSO & COMPANY, ZQuiet, GSK plc, MPowrx, ZYPPAH, LivaNova PLC, Koninklijke Philips N.V., Fisher & Payker Healthcare Limited, Tomed GmbH, SomnoMed, Meditas , AirAvant Medical, AccuMED Corp., General Electric Company, Medtronic, ResMed
-.
The market report covers data from the U.S., Canada and Mexico in North America.
